Introduction
At implantation, the mouse embryo, known as a blastocyst, is made up of three distinct tissues, which are arranged in a specific configuration to develop into a structure known as the egg cylinder. One of these tissues is the pluripotent embryonic epiblast, which gives rise to the fetus and forms a cupshaped epithelium at the distal side of the conceptus. Abutting the epiblast is one of two extraembryonic tissues, the extra-embryonic ectoderm (ExE), which is derived from the trophectoderm and positioned at the proximal side of the embryo, giving rise to the fetal portion of the placenta. The third tissue, the visceral endoderm (VE), gives rise to the yolk sac of the embryo. This forms a monolayer of cells that envelops the other two tissue compartments. These extra-embryonic tissues not only nourish the embryo as it grows, they also provide essential signals to pattern the epiblast, ensuring that the body plan is established correctly. In this protocol, we describe a system to model the early development of the mouse embryo ex vivo that utilizes cells derived from both embryonic and extra-embryonic tissues to mimic in vivo embryogenesis.
Modeling embryogenesis with ESCs alone
Mouse ESCs can be derived from the pre-implantation blastocyst and are transcriptionally equivalent to the epiblast of the mouse embryo just before implantation, at embryonic day 4.5 (E4.5) 1 . These cells are a useful tool for investigating the early development of pluripotent embryonic tissue in the first few days of embryogenesis in vitro. However, when allowed to differentiate in 2D adherent culture, these cells cannot undertake embryogenesis without the support of the in vivo environment. Instead, they differentiate into neural tissue 2 or can be coaxed into generating other lineages by the administration of growth factors to bias cell fate 3, 4 . When cultured in 3D with ECM, mammalian ESCs and their reprogrammed counterparts, induced pluripotent stem cells, have been shown to develop with time into organ-like structures, including fully organized retina and brain-like tissue [5] [6] [7] [8] [9] . The generation of these structures, termed 'organoids', occurs through self-assembly/self-organization of cells from an initially homogeneous pluripotent population. Although some organoid structures exhibit endogenous axial patterning 6, 10 , ESCs in culture fail to reproducibly establish body axes without exogenous signals and do not generate a structure resembling whole-embryonic architecture. Initial attempts to model early post-implantation mouse embryogenesis focused on the use of ESCs alone to generate 3D aggregates of hundreds of cells. This technique leads to the formation of 'embryoid bodies' that can spontaneously induce domains of polarized gene expression 11 . Some of these structures have been termed 'gastruloids', as they sometimes initiate the regionalized expression of germ-layer markers associated with the onset of gastrulation during embryogenesis 12, 13 . However, these structures do not develop as embryos and, consequently, do not recapitulate the specific architecture of the embryo at post-implantation stages, nor do they represent the extra-embryonic lineages present in the mammalian embryo.
When embedded in ECM and when starting from individual cells, ESCs more faithfully mimic embryonic architecture. They develop to make a 'rosette-like' structure similar to the embryonic epiblast at the time of implantation 14 . Just as in the embryo, β1-integrin signaling mediated by laminin in the ECM leads to cell polarization, which in turn underpins the formation of the ESC 'rosette'. At the center of the rosette, a lumen opens, analogous to the opening of the proamniotic cavity during embryogenesis 14 .
Development of the protocol
Given that the embryo at early stages comprises extra-embryonic tissues in addition to the embryonic epiblast, the ExE, and the VE, and that these have been demonstrated to be important for establishing the body plan 15 , we introduced TSCs derived from the ExE of the embryo 16 into co-culture with ESCs embedded in ECM 17 . We also developed a medium to support the culture of ESCs and TSCs simultaneously, and used ECM as a substitute for the basement membrane secreted by the VE, which we showed previously to be critical for epiblast polarization and lumenogenesis in vivo 14 . We demonstrated that ESCs and TSCs in this system could self-assemble into structures that mimicked embryo architecture within 4 d of culture 17 . These structures underwent similar morphogenesis to give rise to a cavity akin to the proamniotic cavity in the mouse egg cylinder, which is shared between the embryonic and extra-embryonic tissues. Despite the fact that only 22% of all structures formed comprised both ESCs and TSCs, when these two types of stem cells met, >90% of the structures developed a characteristic embryo-like morphology, demonstrating the robustness of this model system 17 . Here we provide a step-by-step protocol for the generation of these 'polarized embryo-like structures', also called 'ETS embryos' (ESCs and TSCs in culture), using custom-developed media, ECM, and optical plastic for high-resolution imaging of structures. This method represents a new tool that can be used to investigate early mouse embryogenesis using a tractable stem cell model.
Potential applications of polarized embryo-like structures and comparison to other methods
We showed that our polarized embryo-like structures (ETS embryos) recapitulate proamniotic cavity formation in the mouse embryo and therefore can be used to study how this cavity develops (Fig. 1g,h ). They also recapitulate cell fate decisions and axial patterning events associated with early post-implantation development 17 . We showed that they can develop an area of regionalized mesoderm at the boundary between the ESC and TSC compartments, which is analogous to the domain that marks the onset of gastrulation at the proximo-posterior side of the epiblast 18 . Opposite this region of mesoderm, cells acquire a more anterior-like fate, upregulating genes normally expressed in the anterior epiblast of the E6.5 embryo, such as Pou3f1, Oct4, Slc7a3, and Utf1 (refs 17, 19, 20 ) , indicating changes in the transcriptional program that reflect a gradient of cell fates across the embryonic compartment. Further development of these polarized embryo-like structures leads to specification of a small number of primordial germ cell (PGC)-like cells. Amazingly, these PGC-like cells become specified in the correct spatial location, at the boundary between the ESC and TSC compartments, within the T/Brachyury-positive domain 17 . We showed that this PGC-like cell specification occurs via BMP signaling, as it does in the embryo, and both induction of PGC and mesoderm markers are preceded by the localized induction of Wnt 21, 22 . Thus, polarized embryo-like structures mimic the spatial and temporal events of early mouse embryogenesis 17 . In addition to being a useful tool for studying cavitation in the embryo, because polarized embryolike structures can break their bilateral symmetry to establish an anterior-posterior axis and specify mesoderm in a regionalized manner, these structures can be used to study how mesoderm becomes specified. In comparison to embryoid bodies and the gastruloids derived from them, ETS embryos stand out, in that both whole-embryo architecture and germ-layer specification occur as a result of the activity of endogenous signals provided by the TSC-derived extra-embryonic compartment. This is in contrast to coaxing ESCs in 3D aggregates to differentiate by supplementing the culture medium with growth factors such as recombinant Wnt or BMP [11] [12] [13] . In this respect, ETS embryos are useful for the study of how embryonic and extra-embryonic tissues interact in the embryo to specify embryo architecture and the future body axes. Furthermore, the identity and role of endogenous signals in these embryo-like structures may be deduced by adding inhibitors of known morphogens to the culture system and monitoring the effects on mesoderm specification.
Embryoid bodies and gastruloids that are derived from them constitute only one cell type. As such, they may be useful in the study of how ESCs differentiate in response to the delivery of an exogenous signal. Moreover, although polarized embryo-like structures lack a VE layer, which is critical for natural embryo development, the fact that they are more simple than the real embryo, but still comprise embryonic and extra-embryonic tissues, aids investigation of the interaction between the epiblast and the ExE. This is because the absence of the VE means it cannot confound results by producing its own signals that affect embryogenesis.
In addition to being a valuable tool for investigating the patterning of the body axes, ETS embryos also have several other potential uses in developmental studies. This in vitro model of the mouse embryo can complement in vivo work because the amenability of ESCs and TSCs to genetic manipulation means that they can be used to generate embryo-like structures in which a particular gene of interest has been knocked out. This may be an efficient way to reveal novel functions of genes in early embryogenesis and to perform molecular studies without producing knockout animals, which is both expensive and laborious. This approach may also aid in the identification and study of 'hidden' developmental phenotypes that might be masked in the mouse, as maternally produced protein can compensate when the zygotic genome is compromised. Furthermore, the tissue-specific role of a gene can be easily probed in this system by knocking it out in either the embryonic or extraembryonic cell line only. Although tissue-specific knockouts of mice may require the generation of a construct that includes a tissue-specific promoter, this can be avoided using this embryo-like model, as constitutive promoter systems can be introduced into each cell line independently.
Current limitations of the protocol and potential future directions
Because ESCs and TSCs are mixed in suspension and 3D structures are allowed to grow, the ETS embryo culture is heterogeneous. On average, 22% of all structures in a single well are composed of both stem cell types, whereas the majority of other structures comprise only ESCs and TSCs 17 . Despite this, by plating the recommended cell numbers, a yield of >100 polarized embryo-like structures can be achieved from a single experiment in a single eight-well µ-plate (Ibidi). This is more than what one can analyze per day. We have not tried to optimize this method to generate embryolike structures that would develop beyond the early post-implantation stages. This may require culturing conditions allowing more efficient exchange of gas and nutrients to permit the growth of larger, more complex structures akin to embryos at later developmental stages. As polarized embryolike structures are structurally robust enough to survive manual removal from the Matrigel after 4 d in culture, they can be maintained in suspension using a rotary orbital shaker or in a rotation culture using a spinning bioreactor 23 . Alternatively, a perfusion bioreactor could support structures remaining embedded in ECM.
In addition, the protocol in its current form yields embryo-like structures without a layer to represent the VE, which is the precursor to the yolk sac. One improvement would be to establish a protocol that includes extra-ESCs derived from the primitive endoderm (extra-endoderm 'XEN' stem cells) in co-culture. To do this, the medium composition described here may need to be altered to support the growth and proliferation of all three cell types. Furthermore, it has been shown that XEN cells in conventional culture are more equivalent to the primitive endoderm of the pre-implantation mouse embryo 24, 25 , but cells that are equivalent to the post-implantation VE lineage might be required. Several studies have shown that XEN cells can be coaxed to become more VE-like when treated with BMP 26, 27 , and so it may be that XEN cells would require 'priming' toward a VE-like state in this way before they can be used to generate VE tissue in our embryo-like structures. The use of Matrigel in the current protocol partially compensates for the VE, as this tissue is known to secrete the basement membrane essential for epiblast polarization and lumenogenesis 14 . If VE-like cells were to be incorporated into our embryo-like structures, it is probable that these cells would secrete ECM components, thus providing the culture with exogenous sources of ECM.
Experimental design

Medium optimization
Our approach is based on that developed by Bedzhov and Zernicka-Goetz 14 , in which epiblast architecture is mimicked using ESCs in ECM by introducing TSCs into the system. To develop a medium that would support both types of stem cells in these conditions, we began by mixing 25% (vol/vol) Neurobasal A, 25% (vol/vol) DMEM/F-12, and 50% (vol/vol) MegaCell RPMI medium. We found that medium based on one of these components alone was not sufficient to support the growth of both cell types simultaneously in culture, and that the basal composition that would support ESC and TSC growth at the same time required RPMI medium-which is usually used for conventional TSC culture-to be mixed with Neurobasal-A and DMEM-F/12 media, which is used to make N2B27 for conventional ESC culture. If one or several of these basal components were missing, one or both cell types failed to grow and/or began to differentiate.
The medium we developed also included extra nutrients to promote cell growth and survival in culture, including L-glutamine (or Glutamax) and sodium pyruvate. We supplemented this medium with FGF4 and heparin to promote TSC self-renewal in vitro but excluded the inhibitors PD0325901, CHIR99021, and leukemia inhibitory factor (LIF), which maintain ground state pluripotency in ESCs 28 . We did this because we wanted the ESCs to be able to differentiate in co-culture. This medium also included 10% (vol/vol) FBS. Serum contains undefined factors that promote cell proliferation and differentiation, and is required for mouse blastocysts to develop into egg cylinders in vitro 29, 30 . We hypothesized that serum would provide essential signaling components to ESCs and TSCs in co-culture that might promote self-assembly of embryo-like structures, but we kept the serum content low to minimize the possibility of precocious differentiation. If higher concentrations of serum, such as 20% or 30%, were added to the culture, ETS embryo morphology was compromised, and the structures failed to develop a cavity at their center.
By keeping the serum concentration low in the medium, we found that this medium composition supported the proliferation and formation of rosette-like structures of both ESCs and TSCs in Matrigel; these later self-assembled into 3D structures that resembled the egg cylinder ( Fig. 1 ). These structures more faithfully mimicked the structure of the embryo than the embryoid bodies and had a cell number and tissue volume similar to those of the mouse egg cylinder 17 .
Cells
The use of different cell lines does not affect the efficiency of ETS embryo generation. We have routinely used transgenic reporter ESCs in the co-culture system to report different aspects of ETS embryo development, including mesoderm specification 31 and PGC-like cell specification 32 , or to demarcate the ESC compartment by possession of fluorescent membranes 33 ( Step 1). Cells can also be derived de novo from a transgenic mouse line of interest and used in this protocol. Additional information on the derivation and culture techniques of stem cells from the mouse embryo can be found in Manipulating the Mouse Embryo: a Laboratory Manual 34 . Notably, ESCs and TSCs can still form embryo-like structures even when derived from different mouse strains.
ECM support
We recommend the use of growth factor-reduced Matrigel matrix (Step 13); however, each batch of matrix must be individually tested in the system to ensure reproducibility. Matrigel lots and batches can be tested before ETS embryo generation by embedding ESCs and TSCs separately and culturing them for 72 h to ensure that the cells grow as expected (Steps 14 and 15). For ESCs embedded in Matrigel, a single lumen should develop at the center of the structure within 48 h 14 , and the cells should express the epiblast markers Sox2 or Otx2. TSCs embedded in Matrigel should continue to express ExE markers such as Eomes or Tfap2C, as described below (Fig. 2) .
Imaging ETS embryos can be fixed, stained, and imaged in situ at any time point after plating, (Steps 16-22), but mesodermal lineages appear only after 4-5 d in culture (Fig. 2) (Anticipated results). If liveimaging is required, we recommend plating all the structures in a single plane using the '3D on top' method (Box 1). The '3D on top' method can be used with various dish sizes, depending on the requirements of the experiment. Plating volumes for example dishes (MatTek glass-bottom culture dishes and Ibidi angiogenesis µ-plates) are included in Supplementary Table 1 .
Materials Reagents
• Ready-to-use mitotically inactivated mouse embryonic fibroblasts (MEFs; R&D Systems, cat. no.
PSC001 or MEFs prepared from mouse embryos as described in Box 2) • Mouse trophoblast stem cells (derived as described in Box 3)
• Mouse ESCs derived from the mouse embryo at blastocyst stages (as described in Box 4) or obtained commercially from suppliers such as the Jackson Laboratory 
Box 1 | '3D on top' protocol for ETS-embryo generation • Timing~1 h
For imaging a high number of structures, it is useful to have all the cells in the same plane .For this purpose, a '3D on top' approach (modified from Lee et al. 40 ) can be used. This method is amenable to the use of different optical plates of different sizes, depending on the purpose of the experiment. The modifications to the main procedure required to establish the '3D on top' approach for eight-well μ-plates is described below, and instructions for coating, seeding, and media volumes for plates of different sizes are given in Supplementary Table 1 .
Procedure
1 Thaw Matrigel on ice before beginning the experiment. 2 Cover all eight wells of the μ-plates evenly with 35 μl of liquid Matrigel to cover the surface. 3 Place the plate in the incubator at 37°C for 2 min or until the Matrigel has solidified. 4 Add 100 μl of PBS to each well of the Matrigel-coated plate and place it in the incubator until ready to use. This step prevents the Matrigel from drying out. 5 Trypsinize and wash the cells as described in Steps 2-11 of the main Procedure to yield a 1:1 mixture of ESCs and TSC clumps in PBS. 6 Remove the PBS from each well of the plate and seed the 1:1 mixture of ESCs and TSCs in a 25-μl volume and allow them to attach for 10-15 min in the incubator. c CRITICAL STEP The cells must be allowed to attach in the incubator before proceeding. If the cells do not attach, they will be removed during the later steps, and ETS embryos will not be generated. 7 Prepare a mixture of ETS medium and 10% (vol/vol) liquid Matrigel ; keep this on ice until ready to use. 8 Once the cells have attached, remove the extra PBS with a vacuum pump or by carefully using a pipette, and fill each well of the plate with a mixture of ETS medium and 10% (vol/vol) Matrigel. 9 Culture the cells in 5% CO 2 at 37°C for up to 6 d after plating. Inspect the cultures every day to monitor ETS embryo formation.
• Neurobasal A liquid (Gibco, Life Technologies, cat. no. 10888-022)
• MegaCell RPMI-1640 medium (Sigma-Aldrich, cat. no. M3817)
• N2 supplement (Reagent setup). c CRITICAL Homemade N2 supplement yields better results than commercial N2 (Thermo Fisher Scientific, cat. no. 17502048). The use of some brands of commercial N2 can result in ETS embryos with smaller or no cavities. Before using commercial N2 in this protocol, batch-test the commercial product by using it to make N2B27 medium (described in 'Reagent setup') and use this to culture ESCs embedded in Matrigel. ESC cysts should make lumens within 48 h. c CRITICAL FBS must be tested in the ESC culture before use in the ETS embryo system. To do this, make up FC2iLIF medium (described in 'Reagent setup') and culture ESCs in adherent culture on gelatin in this medium for 2 weeks. Assess ESC growth and proliferation during this time, as well as colony morphology and expression of pluripotency markers. If the FBS is of appropriate quality, then ESCs should become confluent within 48 h of culture, and colonies should be rounded and raised, with tightly packed cells. Expression of pluripotency markers can be tested by immunofluorescence staining to detect expression of Oct4, Nanog, and Sox2 transcription factors, which should be localized to the nucleus. To check for differentiation, cells can also be immunostained for T/Brachyury protein, which should not be expressed in naive pluripotent ESCs. The gold standard test for naive pluripotent ESCs is to perform a chimera assay in which ESCs are introduced into the pre-implantation embryo and their contribution is checked. This is recommended for cell lines that have been derived but not previously validated in this way.
Box 2 | Preparation of mitotically inactivated MEFs • Timing minimum of 3 weeks
A brief procedure follows; more detailed instructions can be found in Nagy et al. 35 . 2 Dissect out the uterine horns in sterile PBS and remove the embryos using fine forceps. 3 Dissect away the brain and red organs from each embryo, then, using a razor blade, mince the tissue until it can be pipetted. 4 Digest the minced tissue using 0.05% (vol/vol) trypsin-EDTA and 100 µl of DNaseI per embryo, and incubate for 15 min at 37°C. 5 Inactivate the trypsin using freshly prepared FC medium and transfer the cell suspension to a Falcon tube. 6 Centrifuge at 300g for 5 min at room temperature (RT, 20°C), then subsequently remove the supernatant and resuspend the cells in fresh FC medium. 7 Plate the cells on gelatin-coated tissue culture dishes and culture overnight at 5% CO 2 and 37°C. 8 Change the medium the following day to remove dead and unattached cells. 9 Expand the cells for 3-5 days until confluent and then inactivate them using Mitomycin-C at 10 µg/ml suspended in PBS. 3 Mate the mice and sacrifice the pregnant females after 4.5 d post coitum to obtain pre-implantation blastocysts. 4 Dissect out the uterus, flush the uterine horns using M2 medium, and collect the blastocyst-stage embryos. 5 Replace the TS cell medium on the MEFs with TSF4H medium and seed one blastocyst per well in the fourwell plates covered with MEFs. 6 Culture overnight at 5% CO 2 and 37°C, and allow the blastocysts to attach to the MEFs and form outgrowths. 7 Replace the medium each day. 8 Once the outgrowths have expanded, aspirate the medium and wash with PBS, then dissociate the outgrowths using 0.05% (vol/vol) trypsin-EDTA. Incubate for 10 min at 5% CO 2 and 37°C. 9 Inactivate the trypsin using 70% MEF-conditioned medium (vol/vol) and 1.5× TSF4H (TS medium containing 37.5 ng/ml FGF4 and 1.5 µg/ml heparin) medium, then disaggregate the outgrowths by pipetting up and down. 10 Incubate at 5% CO 2 and 37°C, and change the medium every other day until TSC colonies begin to appear. The number of days for colonies to appear will vary (usually from 6 to 10 d), but epithelial colonies with clear boundaries should form. Cells other than TSCs may also appear; in this case, pick the colonies of TSCs using a pipette, re-plate in new four-well plates coated with MEFs, and culture at 5% CO 2 and 37°C in TSF4H medium. 11 Continue to expand the TSCs. On average, the cells must be passaged every 3-4 d, or when wells are 80% confluent. Cultures should be split at a ratio of 1:10. To passage TSCs: incubate with 0.05% (vol/vol) trypsin-EDTA for 3-5 min; neutralize with an equal volume of TSC medium; gently disaggregate the cells with a pipette; spin down the cells (1,000g for 3 min at RT); resuspend in TSC medium; and plate on a fresh plate of mitotically inactivated MEFs. 16 12 TSCs can be cultured for a longer term on MEFs or can be cultured in MEF-free conditions on gelatin-coated tissue culture plates by keeping the cells in MEF-conditioned TS cell medium (more details can be found in Tanaka  36 or Rossant   37 ). As a third alternative, TS cells can also be maintained in completely defined conditions; detailed protocols to maintain TSCs in this way have been developed by Kubaczka et al. 38 and by Ohinata et al. 39 . TSCs maintained in all conditions are suitable for the generation of ETS embryos. j PAUSE POINT TSCs can be frozen for storage by freezing at −80°C for up to 6 months or in liquid nitrogen for years in TS freezing medium (10% DMSO, 70% TS cell medium, 20% (vol/vol) FBS).
Additional materials required
• Autoclaved water • Ethanol solution (Sigma-Aldrich, cat. no. 02860-4x25ml)
• Gelatin from cold-water fish skin (Sigma-Aldrich, cat. no. G7765) • BSA (Sigma-Aldrich, cat. no. A3311-50G)
• Triton X-100 (100 ml; Sigma-Aldrich, cat. no. T9284) Reagent setup ! CAUTION All tissue culture reagents must be kept sterile and prepared in a biological safety cabinet suitable for tissue culture (Equipment).
FBS
Heat inactivate the FBS by incubation for 30 min in a water bath at 56°C. Using sterile syringe filters (0.2 µm, 33 mm), filter the inactivated FBS and prepare 40-ml aliquots, then store them at −20°C for up to 6months.
Apo-transferrin solution
To prepare a stock apo-transferrin solution, dissolve 100 mg of the powder in 10 ml of sterile autoclaved water. Spin the solution at 1100g for 3 min at room temperature (RT; 20°C), then transfer to a fresh sterile 1.5-ml Eppendorf tube. Filter, then prepare 1-ml aliquots and store them at −20°C for up to 8 weeks.
Progesterone
To prepare a stock progesterone solution, dissolve 0.006 g of the powder in 10 ml of ethanol. Filter this solution and prepare aliquots in sterile 1.5-ml Eppendorf tubes. Cover the lids of the tubes with Parafilm to prevent evaporation. Store at −20°C for up to 6months.
Sodium selenite
To prepare a stock sodium selenite solution, dissolve 0.006 g of the powder in 10 ml of sterile autoclaved water. Filter the solution and prepare aliquots in sterile 1.5-ml Eppendorf tubes. Store at −20°C for up to 6 months.
Putrescine dihydrochloride
To prepare a stock putrescine dihydrochloride solution, dissolve 0.8 g of the powder in 5 ml of sterile autoclaved water. Filter the solution and prepare aliquots in sterile 1.5-ml Eppendorf tubes. Store at −20°C for up to 6 months.
FGF-4 solution reconstitution
Reconstitute the lipophilized FGF-4 according to the manufacturer's instructions. Prepare a 1,000× (25 µg/ml) stock solution by dilution using a 1× PBS, 0.1% (wt/vol) BSA solution. Prepare aliquots in sterile 1.5-ml Eppendorf tubes and store at −80°C for up to 8 weeks. Do not re-freeze after thawing.
Heparin solution reconstitution
Prepare a 1,000× (1 mg/ml) stock solution (wt/vol) of heparin solution by dissolving 10 mg of heparin in 10 ml of PBS. Prepare aliquots in sterile 1.5-ml Eppendorf tubes and store at −80°C for up to 6 months. Do not re-freeze after thawing.
Gelatin solution
To prepare a 0.1% (wt/vol) gelatin solution, dissolve 1 g of gelatin in 100 ml of water and autoclave the solution. Store at 4°C for up to 1 month.
FC medium
Prepare FC (feeder cell) medium by making a solution composed of the following: DMEM supplemented with 15% (vol/vol) FBS, 2 mM L-glutamine, 0.1 mM 2-ME, 0.1 mM NEAA, 1 mM sodium pyruvate, and 1% (vol/vol) penicillin-streptomycin. Store at 4°C and use within 1 month.
FC2iLIF medium
Supplement the FC medium solution with PD0325901 (1 μM), CHIR99021 (3 μM), and LIF (0.1 mM). Store at 4°C and use within 1 week.
N2 supplement
Prepare a solution composed of the following: DMEM/F-12 supplemented with 10% (vol/vol) human apo-transferrin solution, 10% (vol/vol) bovine albumin fraction V, 25% (vol/vol) human insulin solution, putrescine dihydrochloride (1611 μg/ml), sodium selenite (0.6 μg/ml), and progesterone (0.6 μg/ml). Filter the solution and prepare aliquots in sterile 0.5 ml Eppendorf tubes. Store at −20°C for up to 1 month. Avoid repeated freeze-thaw cycles.
N2B27
Prepare a solution composed of the following: 50% (vol/vol) DMEM/F-12 and 50% (vol/vol) Neurobasal A liquid, supplemented with 2 mM L-glutamine, 0.1 mM 2-ME, 0.5× N2 supplement, and 1× B27 supplement. Store at 4°C and use within 2 weeks.
N2B27 2iLIF
Supplement the N2B27 solution with PD0325901 (1 μM), CHIR99021 (3 μM), and LIF (0.1 mM). Store at 4°C and use within 1 week.
ETS embryo medium
Prepare a solution composed of the following: 40% (vol/vol) MegaCell RPMI, 25% (vol/vol) DMEM/ F-12, and 25% (vol/vol) Neurobasal A liquid supplemented with 10% (vol/vol) FBS, 2 mM L-glutamine, 0.1 mM 2-ME, 0.5 mM sodium pyruvate, 0.25× N2 supplement (made in house), 0.5× B27 supplement, plus 12.5 ng/ml FGF4 and 500 ng/ml heparin. In addition to this, add 1% (vol/vol) penicillin-streptomycin. Store at 4°C and use within 1 week. Alternatively, the complete formulation can be purchased as a ready-to-use formula from Cell Guidance Systems, (cat. no. M13-25).
TS cell medium
Prepare a solution composed of the following: MegaCell RPMI with 20% (vol/vol) FBS, 2 mM L-glutamine, 0.1 mM 2-ME, 1 mM sodium pyruvate, and 1% (vol/vol) penicillin-streptomycin. Store at 4°C and use within 1 month.
TSF4H medium
Supplement the TS cell medium solution with 25 ng/ml recombinant FGF4 and 500 ng/ml heparin. Store at 4°C and use within 1 week.
4% (vol/vol) PFA solution
Dilute the 16% (vol/vol) PFA solution four times in PBS to produce 4% (vol/vol) PFA. Store at 4°C and use within 1 week.
Blocking buffer for antibody incubations
Prepare a solution of PBS with 3% (wt/vol) BSA. Store at 4°C and use within 1 week.
Procedure
Cell culture • Timing minimum of 1 week c CRITICAL The cell lines used in your research should be regularly checked to ensure that they are authentic and are not infected with mycoplasma.
1 Establish both TSC and ESC cultures by carrying out options A and B. Manage ESC and TSC culture and passaging so that passaging days become synchronized. MEF feeder cells need not be removed to begin the ETS embryo experiment. Feeder-free conditions are preferable for ESC culture, but MEFs will not contaminate the culture if they are still present when you start the experiment. When ESCs and TSCs are confluent (80%) on the same day, proceed to the next step to generate ETS embryos. (A) TSC culture (i) Plate mitotically inactivated MEFs in a six-well tissue culture plate at half the density normally used for ESC culture (1 × 10 5 cells/ml). Culture in FC medium at 5% CO 2 and 37°C for at least 24 h, to allow the MEFs to attach to the plate. 
3D embedding of ESCs and TSCs
CRITICAL To minimize the time outside the incubator, it is recommended to process ESCs and TSCs in parallel (Steps 2-7). This can be done by a single researcher; however, if this is not possible, then it is recommended to trypsinize and resuspend the ESCs first, and then keep them in PBS under the tissue culture hood while working with the TSCs. c CRITICAL If it is useful to have all the cells in the same plane (e.g., when imaging multiple structures), a '3D on top' approach can be used as described in Box 1.
Wash the ESCs from
Step 1 with PBS and treat with 0.05% trypsin-EDTA (vol/vol) for 3-4 min at 37°C. 3 Using FC medium, inactivate the trypsin to obtain a single-cell suspension and collect it in a 15-ml Falcon tube. c CRITICAL STEP ESCs should be dissociated to single cells by pipetting. The ESCs can be left in suspension at RT under the tissue culture hood while working with the TSCs. 4 Wash the TSCs from Step 1 with PBS and then treat them with 0.05% trypsin-EDTA (vol/vol) for 4 min at 37°C. 5 Using TS medium, inactivate the trypsin to obtain small clumps of TSCs in suspension. Collect the suspension in a 15-ml Falcon tube. c CRITICAL STEP TSCs should be pipetted gently two to three times using a wide pipette tip (e.g., a P1000 tip), to preserve the small clumps. ? TROUBLESHOOTING 6 If two centrifuges are available, one centrifuge can be used to work with ESCs and another can be used for TSCs in parallel. Centrifuge ESCs for 5 min at 1,000g at RT, and centrifuge the TSC suspension for 3-4 min at 1,000g at RT. 7 After centrifugation of ESCs, resuspend the cells in PBS and centrifuge a second time to 'wash' PD0325901, CHIR99021, and LIF from the ESCs. c CRITICAL STEP Washing of ESCs is important to remove 2iLIF. 8 After centrifugation of TSCs, remove the supernatant and resuspend the pellet gently in RPMI/FBS medium.
c CRITICAL STEP The handling of TSCs should be gentle in order to preserve the small clumps of two to eight cells. The size and number of cells in the TSC clumps can be checked under the tissue culture microscope at each stage of the procedure. Overwashing can reduce the viability of TSCs, so avoid this. 9 After the second centrifugation of ESCs is complete, resuspend them once again in PBS and centrifuge a third time. TSCs can be left at RT in the tissue culture hood while the ESCs are centrifuged for the third time. 10 After the third centrifugation of the ESCs, remove the supernatant and resuspend the cell pellet in PBS to obtain a single-cell suspension. 11 Using a hemocytometer, count~3,000-5,000 ESCs and 3,000-5,000 TSC clumps and mix in a 1:1 suspension in a fresh 15-ml Falcon tube. 12 Centrifuge the mix for 3-4 min at 1,000g at RT, then remove the supernatant carefully using a P200 pipette, without disturbing the cell pellet. 13 Resuspend the pellet in liquid Matrigel (~100 µl for all eight wells of the μ-plate).
c CRITICAL STEP The use of growth-factor-reduced Matrigel is recommended. This should be batch-tested on cells before generating ETS embryos. c CRITICAL STEP Thaw Matrigel on ice. Matrigel must be kept on ice in order to prevent solidification during the cell preparation. c CRITICAL STEP Pipette tips for resuspending the cells should also be kept at 4°C in order to prevent solidification of the Matrigel. 14 Plate the Matrigel-cell suspension in small (10-to 20-μl) drops on μ-plates and allow the matrix to solidify for 2 min at 37°C. Plate one drop per well of the plate. Once the Matrigel is solidified, fill each culture well with ETS-embryo medium and culture in 5% CO 2 at 37°C. ? TROUBLESHOOTING
Co-culture of ESCs and TSCs to generate ETS embryos • Timing maximum 6 d
15 Culture the cells in ETS embryo medium for up to 6 d after plating. Inspect the cultures every day to monitor ETS embryo formation. Change the medium every 48 h or when the cells deplete nutrients, as indicated by the phenol red present in the medium. When the medium requires changing, it will change color from a red-pink color to a 'straw-like' color. Proceed to the next step at the appropriate time point for your experiment (4, 5, or 6 d of culture).
? TROUBLESHOOTING
Immunofluorescence analysis of ETS embryos • Timing 2-3 d
16 Remove the medium from the ETS embryo cultures and rinse with PBS, then fix for 15 min at RT in 4% (vol/vol) ice-cold PFA in PBS. The PFA will lead to the collapse of the Matrigel droplets, and the structures will stick to the optical plastic/glass of the culture dish. ? TROUBLESHOOTING 17 After fixation, rinse the samples twice in PBS for 5 min each, then permeabilize them at RT for 10 min in 0.3% Triton X-100 (vol/vol) and 0.1% (vol/vol) glycine in PBS. j PAUSE POINT After fixation, the samples can be processed immediately for immunofluorescence staining or left in PBS for up to 2 weeks at 4°C. 18 Rinse again in PBS, then perform primary antibody incubation at 4°C overnight in blocking buffer.
Examples of primary antibodies we have used successfully and the recommended dilutions are given in the 'Materials' section. 19 The following day, remove the primary antibody in blocking buffer and wash the samples three times in PBS for 5 min each at RT to remove unbound antibody. 20 Perform secondary antibody incubation with an appropriate antibody in blocking buffer at RT for 2 h. j PAUSE POINT Incubation with secondary antibody can also be performed at 4°C overnight. 21 After incubation, wash the samples three times in PBS for 5 min each at RT, then incubate in DAPI plus PBS for a further 1 h at RT. 22 Remove the DAPI-PBS solution, add PBS to the plates, and use a confocal microscope (Leica or equivalent) to image the ETS embryo structures in situ in the optical plates. ? TROUBLESHOOTING
Troubleshooting
Troubleshooting advice can be found in Table 1 . 
Anticipated results
ESCs and TSCs in close proximity should generate rosette-like structures that come into contact with each other within 48 h. After 72 h, compound structures with a lumen in the ESC compartment should be present, and after 96 h, the two tissue compartments should share a common cavity (Fig. 1) . The efficiency of ETS embryo formation is variable, with an average of 22% of structures per well forming embryo-like structures 17 within 4 d of culture (400 structures were analyzed in culture to calculate this value for efficiency, with 88 structures forming compound structures). At this stage, ETS embryos vary slightly in the number of cells that make up the ESC and the TSC compartments, but they are consistent in sharing a continuous cavity at the center of the structure by 96 h. The compound structures can be considered to be representative ETS embryos if they develop this continuous cavity and if the ESC and TSC compartments occupy~50% of the total tissue volume each 17 . It is important that ESCs be cultured to preserve the naive pluripotent state before use in the protocol. If ESCs are allowed to differentiate in culture, ETS embryo generation can be compromised. Differentiated ESCs can give rise to ETS embryos with disorganized ESC compartments, which fail to organize a columnar epithelium or a continuous proamniotic cavity. Similar structure morphology can be seen when too much serum is used in the ETS embryo medium. If differentiated TSCs are used in this protocol, compound structures fail to grow in culture.
If cell viability is good, 100% of ETS embryos will express lineage markers determining the cell identity in discrete embryonic and extra-embryonic compartments (Fig. 2) . However, mesodermal specification among ETS embryos is variable. We found that 66% of the structures in culture that can be considered to be ETS embryos will specify some cells as mesoderm (by the detection of T/Brachury expression) somewhere in the ESC compartment of the structure. 43% of ETS embryos will specify mesoderm that is 'regionalized', in that it is localized to one side of the long axis of the structure within 4-5 d. 34% of ETS embryos fail to specify any T/Brachyury-positive cells in the ESC compartment.
